Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases

Nyan Y Khin; Madhawa De Silva; Stephen Clarke; Nick Pavlakis; Chris M Rogan; Kevin Ho-Shon; Rodney J Lane

doi:10.1245/s10434-022-11348-z

Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases

Ann Surg Oncol. 2022 Jun;29(6):3387-3389. doi: 10.1245/s10434-022-11348-z. Epub 2022 Feb 11.

Authors

Nyan Y Khin^{1

2}, Madhawa De Silva^{3

4}, Stephen Clarke^{3

4}, Nick Pavlakis^{3

4}, Chris M Rogan^{5

6

7}, Kevin Ho-Shon^{5

7}, Rodney J Lane^{8

6

7

9}

Affiliations

¹ School of Biomedical Engineering, University of Technology Sydney, Ultimo, Australia. nyan@allvascular.com.
² AllVascular Pty Ltd, St Leonards, NSW, Australia. nyan@allvascular.com.
³ Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.
⁴ Kolling Institute of Medical Research, St Leonards, Australia.
⁵ Royal Prince Alfred Hospital, Camperdown, Australia.
⁶ Sydney Adventist Hospital, Wahroonga, Australia.
⁷ Macquarie University Hospital, Macquarie Park, Australia.
⁸ AllVascular Pty Ltd, St Leonards, NSW, Australia.
⁹ Department of Vascular Surgery, North Shore Private Hospital, St Leonards, Australia.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Colorectal Neoplasms* / pathology
Fluorouracil / therapeutic use
Humans
Leucovorin / therapeutic use
Liver Neoplasms* / secondary
Oxaliplatin / therapeutic use
Treatment Outcome

Substances

Oxaliplatin
Leucovorin
Fluorouracil